Jennifer Bushen, Janssen Scientific Affairs, LLC
Janssen Scientific Affairs, LLCJennifer Bushen is the Medical Communication Manager at Janssen Scientific Affairs, Infectious Diseases. She earned her PharmD from Duquesne University, completed her ID Residency at the Hospital of the Univ of Pennsylvania and worked as an ID Pharmacy Specialist at Christiana Care Health System.
Presenter Of 1 Presentation
Oral poster discussion session
PDB0202 - Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral poster discussion session
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 1 Presentation
Oral poster discussion session
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis
Session Name
Room
Abstract Sessions On-Demand Channel